Abstract
Human vascular smooth muscle cells (VSMCs) in culture are an important tool in understanding how VSMCs function and contribute to vessel wall contraction as well as disease. In this chapter, we describe methodologies that enable the investigator to culture large numbers of proliferative VSMCs. These VSMCs are heterogeneous and vary in size, shape, and proliferative capacity depending on the disease state and location of the vessel of origin. Therefore, we also describe techniques to validate their identity as bone fide VSMCs. Briefly, the methods include information on how to dissect the blood vessel to remove the medial layer containing VSMCs, as well as methods on how to propagate these cells, by either allowing VSMCs to migrate from the explanted medial tissue or by enzymatically dispersing the cells from the tissue. Both methods are suitable for culturing VSMCs derived from most vessel types with modifications of the enzyme dispersal method suitable for the isolation of microvessel VSMCs. An important feature of VSMCs in culture is that they lose many of their in vivo contractile properties and so model disease-associated VSMCs in the vessel wall rather than a non-proliferative contractile cell. To overcome this limitation, we also describe alternate methods that enable the study of cultured VSMCs in their contractile state by allowing the VSMCs to remain within an intact vessel ring. Overall, these procedures enable the investigator to undertake a diverse array of experimental assays on cultured VSMCs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chamley-Campbell, J., Campbell, G. R., and Ross, R. (1979) The smooth muscle cell in culture. Physiol Rev 59, 1–61.
Ross, R. (1986) The pathogenesis of atherosclerosis – an update. N Engl J Med 314, 488–500.
Schwartz, S. M., deBlois, D., and O’Brien, E. R. (1995) The intima. Soil for atherosclerosis and restenosis. Circ Res 77, 445–65.
Jonasson, L., Holm, J., Skalli, O., Gabbiani, G., and Hansson, G. K. (1985) Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 76, 125–31.
Hansson, G. K., Jonasson, L., Holm, J., and Claesson-Welsh, L. (1986) Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol 64, 261–8.
Ross, R., and Glomset, J. A. (1976) The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295, 369–77.
Ross, R., and Glomset, J. A. (1976) The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 295, 420–5.
Libby, P. (2000) Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 86, 3J–8J; discussion 8J–9J.
Davies, M. J. (1995) Acute coronary thrombosis – the role of plaque disruption and its initiation and prevention. Eur Heart J 16 Suppl L, 3–7.
Iyemere, V. P., Proudfoot, D., Weissberg, P. L., and Shanahan, C. M. (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260, 192–210.
Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L., and Bottger, B. A. (1990) Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10, 966–90.
Babaev, V. R., Bobryshev, Y. V., Stenina, O. V., Tararak, E. M., and Gabbiani, G. (1990) Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol 136, 1031–42.
Glukhova, M. A., Kabakov, A. E., Frid, M. G., Ornatsky, O. I., Belkin, A. M., Mukhin, D. N., Orekhov, A. N., Koteliansky, V. E., and Smirnov, V. N. (1988) Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 85, 9542–6.
Frid, M. G., Dempsey, E. C., Durmowicz, A. G., and Stenmark, K. R. (1997) Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler Thromb Vasc Biol 17, 1203–9.
Bochaton-Piallat, M. L., Ropraz, P., Gabbiani, F., and Gabbiani, G. (1996) Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 16, 815–20.
Dartsch, P. C., Weiss, H. D., and Betz, E. (1990) Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. Eur J Cell Biol 51, 285–94.
Fujita, H., Shimokado, K., Yutani, C., Takaichi, S., Masuda, J., and Ogata, J. (1993) Human neonatal and adult vascular smooth muscle cells in culture. Exp Mol Pathol 58, 25–39.
Bennett, M. R., Littlewood, T. D., Schwartz, S. M., and Weissberg, P. L. (1997) Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 81, 591–9.
Proudfoot, D., Skepper, J. N., Shanahan, C. M., and Weissberg, P. L. (1998) Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18, 379–88.
Shanahan, C. M., Weissberg, P. L., and Metcalfe, J. C. (1993) Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73, 193–204.
Newman, C. M., Bruun, B. C., Porter, K. E., Mistry, P. K., Shanahan, C. M., and Weissberg, P. L. (1995) Osteopontin is not a marker for proliferating human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15, 2010–8.
Rauch, B. H., Millette, E., Kenagy, R. D., Daum, G., Fischer, J. W., and Clowes, A. W. (2005) Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 280, 17507–11.
Cheng, G. C., Briggs, W. H., Gerson, D. S., Libby, P., Grodzinsky, A. J., Gray, M. L., and Lee, R. T. (1997) Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ Res 80, 28–36.
Gittenberger-de Groot, A. C., DeRuiter, M. C., Bergwerff, M., and Poelmann, R. E. (1999) Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 19, 1589–94.
Lee, C. S., Patton, W. F., Chung-Welch, N., Chiang, E. T., Spofford, K. H., and Shepro, D. (1998) Selective propagation of retinal pericytes in mixed microvascular cell cultures using L-leucine-methyl ester. Biotechniques 25(3), 482–8, 490–2, 494.
Shroff, R. C., Shah, V., Hiorns, M. P., Schoppet, M., Hofbauer, L. C., Hawa, G., Schurgers, L. J., Singhal, A., Merryweather, I., Brogan, P., Shanahan, C., Deanfield, J., and Rees, L. (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23, 3263–71.
Shroff, R. C., McNair, R., Skepper, J. N., Figg, N., Schurgers, L. J., Deanfield, J., Rees, L., and Shanahan, C. M. (2010)Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 21(1): 103–12.
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., and Gabbiani, G. (1986) A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 103, 2787–96.
Arciniegas, E., Sutton, A. B., Allen, T. D., and Schor, A. M. (1992) Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 103 (Pt 2), 521–9.
Shi, Y., O’Brien, J. E., Jr., Fard, A., and Zalewski, A. (1996) Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 16, 1298–305.
Nayak, R. C., Berman, A. B., George, K. L., Eisenbarth, G. S., and King, G. L. (1988) A monoclonal antibody (3 G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med 167, 1003–15.
Shepro, D., and Morel, N. M. (1993) Pericyte physiology. Faseb J 7, 1031–8.
Schlingemann, R. O., Rietveld, F. J., de Waal, R. M., Ferrone, S., and Ruiter, D. J. (1990) Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol 136, 1393–405.
Maguire, J. J., and Davenport, A. P. (1999) Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol 126, 443–50.
Shirinsky, V. P., Birukov, K. G., Sobolevsky, A. V., Vedernikov, Y. P., Posin, E., and Popov, E. G. (1992) Contractile rabbit aortic smooth muscle cells in culture. Preparation and characterization. Am J Hypertens 5, 124S–130S.
Li, S., Sims, S., Jiao, Y., Chow, L. H., and Pickering, J. G. (1999) Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res 85, 338–48.
L’Heureux, N., Stoclet, J. C., Auger, F. A., Lagaud, G. J., Germain, L., and Andriantsitohaina, R. (2001) A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. Faseb J 15, 515–24.
Ewence, A. E., Bootman, M., Roderick, H. L., Skepper, J. N., McCarthy, G., Epple, M., Neumann, M., Shanahan, C. M., and Proudfoot, D. (2008) Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103, e28–34.
Gimbrone, M. A., Jr., and Cotran, R. S. (1975) Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest 33, 16–27.
Schor, A. M., Allen, T. D., Canfield, A. E., Sloan, P., and Schor, S. L. (1990) Pericytes derived from the retinal microvasculature undergo calcification in vitro. J Cell Sci 97 (Pt 3), 449–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Proudfoot, D., Shanahan, C. (2012). Human Vascular Smooth Muscle Cell Culture. In: Mitry, R., Hughes, R. (eds) Human Cell Culture Protocols. Methods in Molecular Biology, vol 806. Humana Press. https://doi.org/10.1007/978-1-61779-367-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-61779-367-7_17
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-366-0
Online ISBN: 978-1-61779-367-7
eBook Packages: Springer Protocols